UCB Ocular Myasthenia Gravis
Purpose of the study?
The purpose of the study is to demonstrate the efficacy, safety and tolerability of rozanolixizumab compared with placebo in the treatment of adult study participants with Ocular Myasthenia Gravis.
Notable Inclusion Criteria: Weakness in muscles of the eye but normal strength in all other facial, bulbar, and limb muscles.
There are additional inclusion criteria for this study which may be found at clinicaltrials.gov.